Cargando…

Corrigendum to “Relapse of prostate cancer from the viewpoint of total gland volume kinetics theory” by Hiroki Watanabe

Detalles Bibliográficos
Autor principal:	Watanabe, Hiroki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854116/ https://www.ncbi.nlm.nih.gov/pubmed/27004540 http://dx.doi.org/10.4103/1008-682X.175788

Ejemplares similares

Relapse of prostate cancer from the viewpoint of total gland volume kinetics theory
por: Watanabe, Hiroki
Publicado: (2015)

Patient Selection for Bronchoscopic Lung Volume Reduction [Corrigendum]
Publicado: (2020)

Corrigendum: Estimation of C. elegans cell- and tissue volumes
Publicado: (2022)

Development of cabozantinib for the treatment of prostate cancer [Corrigendum]
Publicado: (2014)

Corrigendum to “Value of Fused (18)F-Choline-PET/MRI to Evaluate Prostate Cancer Relapse in Patients Showing Biochemical Recurrence after EBRT: Preliminary Results”
por: Piccardo, Arnoldo, et al.
Publicado: (2016)

Corrigendum: Salivary gland ultrasound is linked to the autoimmunity profile in patients with primary Sjögren’s syndrome
Publicado: (2018)

Corrigendum to “Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis”
Publicado: (2021)

Efficacy of bronchoscopic lung volume reduction: a meta-analysis [Corrigendum]
Publicado: (2014)

Robot-Assisted Total Hip Arthroplasty for Arthrodesed Hips [Corrigendum]
Publicado: (2020)

Corrigendum to “Component Asymmetry in Bilateral Cementless Total Hip Arthroplasty”
por: Woo, Seung Hun, et al.
Publicado: (2023)

Corrigendum to: “Conserved and Unique Putative Effectors Expressed in the Salivary Glands of Three Related Gall Midge Species”
Publicado: (2019)

Corrigendum to “HDR Brachytherapy in the Management of High-Risk Prostate Cancer”
por: Masson, Susan, et al.
Publicado: (2016)

Evaluating the Therapeutic Potential of Zanubrutinib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: Evidence to Date [Corrigendum]
Publicado: (2020)

Corrigendum to Clinical outcomes of volume of disease on patients receiving enzalutamide vs. abiraterone acetate plus prednisone as first-line therapy for metastatic castration resistant prostate cancer
Publicado: (2023)

Smartphone Health Assessment for Relapse Prevention (SHARP): a digital solution toward global mental health – CORRIGENDUM
por: Rodriguez-Villa, Elena, et al.
Publicado: (2021)

Treatment of Intractable Pneumothorax with Emphysema Using Endobronchial Watanabe Spigots
por: Lee, Doo Yun, et al.
Publicado: (2013)

Excessive anterior cervical muscle tone affects hyoid bone kinetics during swallowing in healthy individuals [Corrigendum]
Publicado: (2018)

Corrigendum to: Application of multi-trait bayesian decision theory for parental genomic selection
por: Villar-Hernández, Bartolo de Jesús, et al.
Publicado: (2021)

Family Wellbeing and Sexual Health of Patients Receiving Treatment for Prostate Cancer [Corrigendum]
Publicado: (2023)

A Prospective Study on the Efficacy of Cognitive Targeted Transrectal Ultrasound Prostate Biopsy in Diagnosing Clinically Significant Prostate Cancer [Corrigendum]
Publicado: (2021)

HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer [Corrigendum]
Publicado: (2019)

Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy [Corrigendum]
Publicado: (2022)

[Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway
por: Ji, Junpeng, et al.
Publicado: (2023)

Corrigendum to “Semiphysiological versus Empirical Modelling of the Population Pharmacokinetics of Free and Total Cefazolin during Pregnancy”
por: van Hasselt, J. G. Coen, et al.
Publicado: (2015)

Corrigendum to “Relapsed multiple myeloma manifesting as extramedullary plasmacytoma of the breast: Imaging findings” [Radiology Case Reports 14 (2019) 584–587]
por: Urano, Misugi, et al.
Publicado: (2020)

Corrigendum to “Valorization of Oued Sebou Natural Sediments (Fez-Morocco Area) as Adsorbent of Methylene Blue Dye: Kinetic and Thermodynamic Study”
por: Dra, Abdelaziz, et al.
Publicado: (2020)

Corrigendum: Acknowledgments. Effect of Photoselective Vaporization Prostatectomy on Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia With or Without Intravesical Prostatic Protrusion
por: Kim, Myung Soo, et al.
Publicado: (2013)

Corrigendum to “A Longitudinal Examination of the Hopelessness Theory of Depression in People Who Have Multiple Sclerosis”
por: Kneebone, I. I., et al.
Publicado: (2020)

Corrigendum to “Use of a Lower-Volume, Surface Pesticide Spray Conserves Spider Assemblages in a Tea Field”
Publicado: (2018)

Corrigendum to ‘Remembering Professor José Baselga’: [ESMO Open Volume 6, Issue 3, June 2021, 100121]
por: Tabernero, J.
Publicado: (2021)

The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasia [Corrigendum]
Publicado: (2013)

Corrigendum to: Genomic mating in outbred species: predicting cross usefulness with additive and total genetic covariance matrices
por: Wolfe, Marnin D, et al.
Publicado: (2021)

Corrigendum to “Central venous disease in hemodialysis patients” [Volume 38, Issue 3, September 2019, Pages 309-317]
por: Park, Hoon Suk, et al.
Publicado: (2020)

Corrigendum to “Amiodarone Induced Hyponatremia Masquerading as Syndrome of Inappropriate Antidiuretic Hormone Secretion by Anaplastic Carcinoma of Prostate”
por: Dutta, Pinaki, et al.
Publicado: (2018)

Corrigendum to “Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy”
por: Neubecker, Katherine, et al.
Publicado: (2017)

Synergistic Effect Of A Retinoid X Receptor-Selective Ligand Bexarotene And Docetaxel In Prostate Cancer [Corrigendum]
Publicado: (2019)

Corrigendum: IC50: an unsuitable measure for large-sized prostate cancer spheroids in drug sensitivity evaluation
Publicado: (2023)

Corrigendum to ’To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection’[Multiple sclerosis and related disorders vol. 65 (2022) 104014]
por: Stastna, Dominika, et al.
Publicado: (2023)

Corrigendum: Two Different Total Hip Arthroplasties for Hartofilakidis Type C1 Developmental Dysplasia of Hip in Adults
Publicado: (2018)

Corrigendum: Results of crowe Type IV developmental dysplasia of hip treated by subtrochantric osteotomy and total hip arthroplasty
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qh7nelsm6kf4n2e1vorpl4o33i